Therapeutic Expertise
Cardiology - Structural Heart Disease
Cardiovascular Experience
D-TARGET has a long tradition in cardiovascular research for medical devices. We have supported the approval of many new devices as well as post marketing studies on the following devices:
• Stents (Bare Metal and Drug Eluting)
• EP - Ablation Systems
• Valve Replacement
• CRT Devices
• Baroreflex Stimulator
• Cardiac Assist Devices
• Cardiac Bioprosthesis
• Cardiac Pressure Monitoring Devices
• Catheter (Laser and Drug Eluting)
• Drug Eluting Balloon
• Mechanical Reperfusion Device
• PFO Closure Devices
• Thoracic Endoprosthesis and Stent Grafts
D-TARGET has managed 56 cardiology medical device studies treating approximately 22,000 patients within the past 9 years. We have also provided consulting services for an additional 20 cardiology projects and are currently supporting trials in the US and throughout Europe, Scandinavia and Israel.
Structural Heart Disease Experience
D-TARGET is highly experienced in supporting interventional cardiology studies, especially in percutaneus approach.
We supported over the last years 5 structural heart disease trials with more then 500 patients involved throughout Europe and Israel.
KOL Network
D-TARGET is currently working with notable sites and key opinion leaders in Europe and the US.
Europe:
Leiden, Zwolle, Rotterdam, Leuven, Brussels, Geneva, Bern, Basel, Thun, Fribourg, Leipzig, Bad Nauheim, Dresden, Berlin, Munich, Bad Segeberg, Hamburg, Bad Krozingen, Munich, Bad Oyenhausen, Coburg, Vienna, Graz, Prague, Warsaw, Monaco, London, Leicester, Manchester, Milano,Lugano, Rome, Madrid, Barcelona, Stockholm, Malmö, Kopenhagen, Oslo, Rennes, Paris, Nantes, Toulouse and Bordeaux to just name a few.
US:
Boston, Philadelphia, New York, Austin, Columbus, Chicago, Oklahoma City, Cleveland, Birmingham, Charleston, Rochester, Ann Arbor, Charlottesville, San Francisco, Fresno, San Diego, Cincinnati, Denver, Los Angeles, Plano, New Haven
Cardiology ( Structural Heart Disease ) Study & Consulting Experience details
Device Type | Study Type | Sites | Patients | Services | Region | |
Atrial Septal Defect (Pediatric) | PFO Closure Device | Pilot | 6 | 30 | CM, PM, RA | WE |
Atrial Septal Defect (Pediatric) | PFO Closure Device | Registry | 15 | 200 | CM, MM, PM, RA | WE |
Atrial Septal Defect | PFO Closure Device | Registry | 15 | 250 | CM, MM, PM, RA | NA, WE |
Patent Foramen Ovale/ Cryptogenic Cerebral Ischemia | PFO Closure Device | Pilot | 1 | 12 | CM, DM, PM, RA | WE |
Patent Foramen Ovale/ Cryptogenic Cerebral Ischemia | PFO Closure Device | Pilot | 1 | 50 | CM, DM, MM, PM, QA, RA | WE |
Services |
| Regions | |
BS CM DB DM FS IT MM MW PM QA RC RA SS Full Service | Biostatistics Clinical Monitoring & Management Data Safety Monitoring Board Data Management Functional Sourcing IVRS/ IWRS Medical Management Medical Writing Project Management Quality Assurance Research Centers Regulatory Affairs Study Start-Up 4 or more services incl. BS, CM, DM & PM | NA WE CE EE AF AP AU CA ME NO SA
| North America Western Europe Central Europe Eastern Europe Africa Asia/Pacific Australasia Central America Middle East Nordics South America
|